Epidemiology of resistance of carbapenemase-producing Klebsiella pneumoniae to ceftazidime-avibactam in a Chinese hospital.

Abstract

Aims Klebsiella pneumoniae has been reported to develop increased antibiotic resistance. Ceftazidime‐avibactam (CZA) is a novel antibiotic with activity against serine‐lactamase. Here, we investigated the sensitivity of carbapenem‐resistant K. pneumoniae (CRKP) to CZA and the mechanisms of drug resistance in our hospital.Methods and ResultsPatient characteristics were obtained from medical records. K. pneumoniae and its antibiotic susceptibility were determined using the Vitek‐2 Compact instrument. The antibiotic resistance genes KPC, NDM, OXA‐48, VIM, IMP, CIM, SPM, TMB, SMB, SIM, AIM and DIM were detected using real‐time PCR. Multilocus sequence typing was used for genetic RELATEDNESS analysis. In total, 121 CRKP strains were isolated from patients in the intensive care unit (51·2%), senior ward (12·4%) and neurosurgery department (10%). With an average age of 72·5 years, most patients were in care for respiratory (34·7%), brain (20·7%), digestive tract (13·2%) and cardiovascular (8·3%) diseases. Specimens were predominantly obtained from sputum (39·67%), urine (29·75%) and blood (6·61%).ConclusionOf 23 CZA‐resistant CRKP strains (19·01%), ST11 being the most common at 56·52%, 11 NDM‐1‐positive (47·83%) and four NDM‐5‐positive (17·39%) strains were detected.Significance and Impact of the StudyOur study indicates that CZA resistance occurs in ~19·01% CRKP strains and that bla NDM‐1 and bla NDM‐5 might be critical for resistance.